Literature DB >> 18437544

Cognitive functioning in chronic acquired hepatocerebral degeneration.

Andrea Stracciari1, Katia Mattarozzi, Roberto D'Alessandro, Elisa Baldin, Maria Guarino.   

Abstract

CNS involvement is frequent in patients with chronic liver disease, resulting in overt or subclinical ("minimal") encephalopathy. Occasionally, patients liver cirrhosis may develop a progressive encephalopathy known as chronic acquired hepatocerebral degeneration (CAHD), presenting with neuropsychiatric changes and movement disorders. In patients affected by CAHD cognitive dysfunction is the rule, but to date this aspect has not been systematically studied. Our aim was to characterize the neuropsychological profile of cognitive impairment associated with CAHD. Eight patients with CAHD received extensive neuropsychological assessment, far from episodes of acute liver decompensation. Their cognitive performances were compared with those of 8 patients with cirrhosis free from CAHD or overt hepatic encephalopathy (HE) and with those of 8 healthy controls matched for age, sex and educational level. Patients with CAHD revealed a significant impairment of visuo-spatial attention compared to healthy controls, and a lower performance on a single task of visual search and sequencing when compared to cirrhotics without CAHD. Our findings support the hypothesis of a linear decline in attentional performances of patients with chronic liver disease, starting from cognitively intact patients, moving toward patients with minimal HE, and finally progressing to those with overt HE and CAHD.

Entities:  

Mesh:

Year:  2008        PMID: 18437544     DOI: 10.1007/s11011-008-9088-3

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  20 in total

1.  [Chronic acquired hepatocerebral degeneration: the role of manganese and treatment by endovascular occlusion of a porto-systemic shunt].

Authors:  B Condat; A Dusoleil; M Bernardeau; A Roche; G Pelletier; C Buffet
Journal:  Gastroenterol Clin Biol       Date:  1999-02

2.  Minimal hepatic encephalopathy: longitudinal effects of liver transplantation.

Authors:  Katia Mattarozzi; Andrea Stracciari; Luca Vignatelli; Roberto D'Alessandro; Maria Cristina Morelli; Maria Guarino
Journal:  Arch Neurol       Date:  2004-02

3.  MR imaging of acquired hepatocerebral degeneration.

Authors:  J Kulisevsky; J Ruscalleda; J M Grau
Journal:  AJNR Am J Neuroradiol       Date:  1991 May-Jun       Impact factor: 3.825

Review 4.  Characteristics of minimal hepatic encephalopathy.

Authors:  Piero Amodio; Sara Montagnese; Angelo Gatta; Marsha Y Morgan
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

5.  Chronic acquired hepatocerebral degeneration: case reports and new insights.

Authors:  M S Jog; A E Lang
Journal:  Mov Disord       Date:  1995-11       Impact factor: 10.338

6.  Effect of liver transplantation on neurological manifestations in Wilson disease.

Authors:  A Stracciari; A Tempestini; A Borghi; M Guarino
Journal:  Arch Neurol       Date:  2000-03

7.  Acquired hepatocerebral degeneration: MR and pathologic findings.

Authors:  J Lee; D Lacomis; S Comu; J Jacobsohn; E Kanal
Journal:  AJNR Am J Neuroradiol       Date:  1998-03       Impact factor: 3.825

8.  Distinguishing between clinical and minimal hepatic encephalopathy on the basis of specific cognitive impairment.

Authors:  Katia Mattarozzi; Claudio Campi; Maria Guarino; Andrea Stracciari
Journal:  Metab Brain Dis       Date:  2005-09       Impact factor: 3.584

Review 9.  Attention, memory, and cognitive function in hepatic encephalopathy.

Authors:  Karin Weissenborn; Kathrin Giewekemeyer; Susanne Heidenreich; Martin Bokemeyer; Georg Berding; Björn Ahl
Journal:  Metab Brain Dis       Date:  2005-12       Impact factor: 3.584

10.  Distribution of cerebral lesions in acquired hepatocerebral degeneration.

Authors:  M H Finlayson; B Superville
Journal:  Brain       Date:  1981-03       Impact factor: 13.501

View more
  8 in total

Review 1.  Acquired hepatocerebral degeneration.

Authors:  Joseph Ferrara; Joseph Jankovic
Journal:  J Neurol       Date:  2009-02-17       Impact factor: 4.849

2.  Acquired hepatocerebral degeneration (AHD): a peculiar neurological impairment in advanced chronic liver disease.

Authors:  A Pigoni; F Iuculano; C Saetti; L Airaghi; L Burdick; S Spreafico; M Curioni; R Lombardi; L Valenti; A L Fracanzani; S Fargion
Journal:  Metab Brain Dis       Date:  2017-09-16       Impact factor: 3.584

3.  Chronic acquired hepatocerebral degeneration: effects of liver transplantation on neurological manifestations.

Authors:  A Stracciari; E Baldin; L Cretella; L Delaj; R D'Alessandro; M Guarino
Journal:  Neurol Sci       Date:  2011-02-17       Impact factor: 3.307

4.  Acquired hepatocerebral degeneration: A case report.

Authors:  Clarice Listik; Gislaine Cristina Lopes Machado-Porto; Maira Okada de Oliveira; Fábio Henrique de Gobbi Porto
Journal:  Dement Neuropsychol       Date:  2012 Jan-Mar

5.  Chronic acquired hepatocerebral degeneration presenting with Meige's syndrome and behavioral symptoms fully reversed by liver transplantation.

Authors:  Andrea Stracciari; Luca Spinardi; Maria Guarino
Journal:  Neurol Sci       Date:  2021-07-19       Impact factor: 3.307

6.  Atypical neuroimaging findings in patients with acquired hepatocerebral degeneration.

Authors:  Xiaoyu Dong; Jianfei Nao
Journal:  Neurol Sci       Date:  2019-09-07       Impact factor: 3.307

Review 7.  Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma.

Authors:  Bruno Sangro; Stephen L Chan; Tim Meyer; María Reig; Anthony El-Khoueiry; Peter R Galle
Journal:  J Hepatol       Date:  2020-02       Impact factor: 25.083

Review 8.  Recent Updates on Acquired Hepatocerebral Degeneration.

Authors:  Hae-Won Shin; Hee Kyung Park
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2017-09-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.